A Council of Europe conference held in Moscow, Russia, has heard from the host government that it is "stepping up its own battle to sweep fake drugs off the market," according to a report in the medical journal, The Lancet. Critics in the local drug industry complain that the measures introduced are "misguided."
10% of local drugs are thought to be fakes
Fake drug production in Russia is estimated to be worth about $300.0 million per year, with up to one-tenth of all locally manufactured products affected. A recent crackdown by the Russian Federal Agency for Monitoring Health and Social Development (Roszdravnadzor) has apparently made significant inroads into the problem, including the revoking of production licenses for facilities found to be involved in drug counterfeiting.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze